These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2943294)

  • 1. Lack of antiplatelet activity of the new coumarin derivative 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy- carboxylmethoxycoumarin under in vivo conditions in man.
    Luzzatto G; Fabris F; Dal Bo Zanon R; Girolami A
    Arzneimittelforschung; 1986 Jun; 36(6):972-3. PubMed ID: 2943294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy carboxyl methoxy coumarin (AD6) on aggregation, arachidonic acid metabolism and thromboxane B2 formation in human platelets.
    Galli C; Agradi E; Petroni A; Socini A
    Pharmacol Res Commun; 1980 Apr; 12(4):329-37. PubMed ID: 7393988
    [No Abstract]   [Full Text] [Related]  

  • 3. AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonyl-meth oxy coumarin) inhibits the release of arachidonic acid in human platelets stimulated by thrombin.
    Porcellati S; Costantini V; Prosdocimi M; Pistolesi R; Porrovecchio P; Nenci GG; Goracci G
    Thromb Res; 1987 Jul; 47(1):15-24. PubMed ID: 3116710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on inhibition of platelet aggregation by carbocromen (author's transl)].
    Resag K; Melzer G; Nitz RE
    Arzneimittelforschung; 1976 Feb; 26(2):209-13. PubMed ID: 947200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmet hox y coumarin) on human platelets in vitro.
    Prosdocimi M; Zatta A; Gorio A; Zanetti A; Dejana E
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):305-10. PubMed ID: 3012375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy- carbonylmethoxycoumarin) on washed human platelet aggregation induced by platelet activating factor (PAF) and epinephrine.
    Zanetti A; Zatta A; Prosdocimi M; Dejana E
    Eur J Pharmacol; 1986 Aug; 128(1-2):119-27. PubMed ID: 2944757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
    Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
    Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery.
    Prosdocimi M; Finesso M; Tessari F; Gorio A; Languino LR; de Gaetano G; Dejana E
    Thromb Res; 1985 Aug; 39(4):399-409. PubMed ID: 3840290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coffee extracts inhibit platelet aggregation in vivo and in vitro.
    Bydlowski SP; Yunker RL; Rymaszewski Z; Subbiah MT
    Int J Vitam Nutr Res; 1987; 57(2):217-23. PubMed ID: 3115908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative method of measuring platelet ATP released in vitro in the presence of various aggregating agents].
    Jung G; Hénon P
    Pathol Biol (Paris); 1984 Sep; 32(7):772-8. PubMed ID: 6436777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
    Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
    J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects.
    Legnani C; Frascaro M; Guazzaloca G; Ludovici S; Cesarano G; Coccheri S
    Arzneimittelforschung; 1993 Feb; 43(2):119-22. PubMed ID: 8457236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition and aggregation of canine blood platelets: basic mechanisms of function and differences because of breed origin.
    Clemmons RM; Meyers KM
    Am J Vet Res; 1984 Jan; 45(1):137-44. PubMed ID: 6422804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbocromen inhibits arachidonic acid-induced platelet aggregation and TXA2 formation.
    Heinroth I; Förster W
    Prostaglandins Leukot Med; 1984 Apr; 14(1):13-4. PubMed ID: 6427789
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
    Zahavi J; Zahavi M
    Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro effect of amrinone on platelet aggregation in human whole blood.
    Pattison A; Eason CT; Bonner FW
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):261-4. PubMed ID: 3083485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of various stimulators on cyclooxygenase activity, platelet aggregation and TxB2 synthesis after using a platelet inhibitor (Aspro Clear) in vivo and in vitro].
    Gorczynska E; James M; Wegrzynowicz R; Masiak M
    Wiad Lek; 1985 Jul; 38(13):920-5. PubMed ID: 3933184
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.